XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
0.00 (0.00%)
At close: Aug 22, 2025, 3:59 PM
3.26
1.87%
After-hours: Aug 22, 2025, 04:43 PM EDT

XBiotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 2.62M n/a n/a n/a 300K 1.68M 1.53M 500K 4.5M 4.52M 4.53M 4.85M
Cost of Revenue
439K 442K n/a 439K n/a n/a 434K 432K 435K 443K 16K 215K 207K 213K 1.05M 1.11M 1.36M 2.3M
Gross Profit
-439K -442K n/a -439K n/a n/a 2.19M -432K -435K -443K 284K 1.47M 1.32M 287K 3.45M 3.41M 3.17M 2.55M
Operating Income
-6.34M -13.55M -8.75M -7.9M -14.97M -10.85M -8.59M -8.52M -13.26M -7.14M -8.16M -6.39M -12.09M -7.84M -7.19M -3.73M -10.61M -3.55M
Interest Income
1.53M 1.5M 2.1M 2.37M 2.69M 2.66M 2.6M 2.53M 2.51M 2.78M 2.47M 1.01M 241K 101K 110K 125K 123K 109K
Pretax Income
-1.73M -10.86M -10.55M -5.01M -13.03M -9.98M -4.73M -7.06M -8.67M -3.85M -2.63M -10.26M -14.25M -6.45M -7.67M -5.05M -9.69M -3.04M
Net Income
-1.76M -10.88M -10.51M -5.01M -13.01M -10M -4.63M -7.36M -8.74M -3.82M -3.2M -12.66M -11.64M -5.39M -6.47M -3.26M -5.12M -2.57M
Selling & General & Admin
1M 1.93M 927K 777K 1.98M 596K 349K 973K 1.99M 915K 1.13M 840K 3.02M 1.31M 1.87M 1.54M 4.52M 1.47M
Research & Development
5.34M 11.62M 7.82M 7.13M 12.98M 9.82M 7.8M 7.55M 11.27M 6.23M 7.32M 7.01M 10.39M 6.82M 8.78M 5.6M 9.25M 4.63M
Other Expenses
n/a n/a n/a n/a n/a -200K 3K n/a 750K 130K -2K n/a -119K n/a n/a n/a -2K -10K
Operating Expenses
6.34M 13.55M 8.75M 7.9M 14.97M 10.42M 8.15M 8.52M 13.26M 7.14M 8.45M 7.85M 13.42M 8.13M 10.65M 7.14M 13.77M 6.1M
Interest Expense
n/a 88K 204K 203K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -432K -434K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.34M 13.55M 8.75M 7.9M 14.97M 10.85M 8.59M 8.52M 13.26M 7.14M 8.46M 8.07M 13.62M 8.35M 11.69M 8.25M 15.13M 8.4M
Income Tax Expense
28K 29K -41K 9K -25K 25K -99K 308K 71K -37K 578K 2.4M -2.61M -1.06M -1.2M -1.79M -4.57M -477K
Shares Outstanding (Basic)
30.49M 30.49M 30.46M 30.47M 30.46M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.04M 30.34M 30.34M 29.99M 29.42M
Shares Outstanding (Diluted)
30.49M 30.49M 30.46M 30.47M 30.46M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.44M 30.04M 30.34M 30.34M 29.99M 29.42M
EPS (Basic)
-0.06 -0.36 -0.34 -0.16 -0.43 -0.33 -0.15 -0.24 -0.29 -0.13 -0.11 -0.42 -0.38 -0.18 -0.21 -0.11 -0.17 -0.09
EPS (Diluted)
-0.06 -0.36 -0.34 -0.16 -0.43 -0.33 -0.15 -0.24 -0.29 -0.13 -0.11 -0.42 -0.38 -0.18 -0.21 -0.11 -0.17 -0.09
EBITDA
-1.29M -10.32M -9.91M -4.36M -14.53M -10.42M -8.15M -8.09M -12.82M -6.7M -7.72M -5.66M -11.37M -7.13M -6.49M -3.04M -9.97M -2.93M
EBIT
-1.73M -10.77M -10.35M -4.8M -14.97M -10.85M -8.59M -8.52M -13.26M -7.14M -8.16M -6.39M -12.09M -7.84M -7.19M -3.73M -10.61M -3.55M
Depreciation & Amortization
439K 442K 439K 439K 435K 432K 434K 432K 435K 443K 443K 734K 727K 710K 702K 687K 638K 621K